
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
LncRNA AFAP1-AS1 Supresses miR-139-5p and Promotes Cell Proliferation and Chemotherapy Resistance of Non-small Cell Lung Cancer by Competitively Upregulating RRM2
Na Huang, Wei Guo, Ke Ren, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 80
Na Huang, Wei Guo, Ke Ren, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 80
Showing 1-25 of 80 citing articles:
Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 4002-4002
Open Access | Times Cited: 214
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 4002-4002
Open Access | Times Cited: 214
Long non-coding RNAs in the doxorubicin resistance of cancer cells
Saeed Ashrafizaveh, Milad Ashrafizadeh, Ali Zarrabi, et al.
Cancer Letters (2021) Vol. 508, pp. 104-114
Open Access | Times Cited: 150
Saeed Ashrafizaveh, Milad Ashrafizadeh, Ali Zarrabi, et al.
Cancer Letters (2021) Vol. 508, pp. 104-114
Open Access | Times Cited: 150
RRM2 Regulates Sensitivity to Sunitinib and PD‐1 Blockade in Renal Cancer by Stabilizing ANXA1 and Activating the AKT Pathway
Wei Xiong, Bin Zhang, Haixin Yu, et al.
Advanced Science (2021) Vol. 8, Iss. 18
Open Access | Times Cited: 103
Wei Xiong, Bin Zhang, Haixin Yu, et al.
Advanced Science (2021) Vol. 8, Iss. 18
Open Access | Times Cited: 103
LncRNA LINC00969 promotes acquired gefitinib resistance by epigenetically suppressing of NLRP3 at transcriptional and posttranscriptional levels to inhibit pyroptosis in lung cancer
Jiali Dai, Tianyu Qu, Dandan Yin, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 5
Open Access | Times Cited: 54
Jiali Dai, Tianyu Qu, Dandan Yin, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 5
Open Access | Times Cited: 54
Inhibiting RRM2 to enhance the anticancer activity of chemotherapy
Yaqiong Zhan, Lushun Jiang, Xuehang Jin, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110996-110996
Open Access | Times Cited: 90
Yaqiong Zhan, Lushun Jiang, Xuehang Jin, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110996-110996
Open Access | Times Cited: 90
Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
ACS Combinatorial Science (2020) Vol. 22, Iss. 12, pp. 669-700
Open Access | Times Cited: 83
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
ACS Combinatorial Science (2020) Vol. 22, Iss. 12, pp. 669-700
Open Access | Times Cited: 83
Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma
Anran Zhang, Jinpo Yang, Chao Ma, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 82
Anran Zhang, Jinpo Yang, Chao Ma, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 82
Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin
Yunlong Jia, Cong Tian, Hongyan Wang, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 49
Yunlong Jia, Cong Tian, Hongyan Wang, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 49
miR-140-3p impedes the proliferation of human cervical cancer cells by targeting RRM2 to induce cell-cycle arrest and early apoptosis
Jiajia Ma, Fan Zhang, Ping Sun
Bioorganic & Medicinal Chemistry (2019) Vol. 28, Iss. 3, pp. 115283-115283
Closed Access | Times Cited: 42
Jiajia Ma, Fan Zhang, Ping Sun
Bioorganic & Medicinal Chemistry (2019) Vol. 28, Iss. 3, pp. 115283-115283
Closed Access | Times Cited: 42
Independent prognostic implications of RRM2 in lung adenocarcinoma
Chao Ma, Huan Luo, Jing Cao, et al.
Journal of Cancer (2020) Vol. 11, Iss. 23, pp. 7009-7022
Open Access | Times Cited: 42
Chao Ma, Huan Luo, Jing Cao, et al.
Journal of Cancer (2020) Vol. 11, Iss. 23, pp. 7009-7022
Open Access | Times Cited: 42
N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway
Chengjie Lin, Yan Wang, Yihong Dong, et al.
Biology Direct (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 24
Chengjie Lin, Yan Wang, Yihong Dong, et al.
Biology Direct (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 24
Overexpression of RRM2 is related to poor prognosis in oral squamous cell carcinoma
Shuo Wang, Xiaolong Wang, Zhi‐Zhong Wu, et al.
Oral Diseases (2020) Vol. 27, Iss. 2, pp. 204-214
Closed Access | Times Cited: 34
Shuo Wang, Xiaolong Wang, Zhi‐Zhong Wu, et al.
Oral Diseases (2020) Vol. 27, Iss. 2, pp. 204-214
Closed Access | Times Cited: 34
LncRNA DHRS4-AS1 Inhibits the Stemness of NSCLC Cells by Sponging miR-224-3p and Upregulating TP53 and TET1
Fei Yan, Wei Zhao, Xiaoyue Xu, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 33
Fei Yan, Wei Zhao, Xiaoyue Xu, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 33
Senescence Osteoblast-Derived Exosome-Mediated miR-139-5p Regulates Endothelial Cell Functions
Qing Lü, Hao Qin, Haitao Tan, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 31
Qing Lü, Hao Qin, Haitao Tan, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 31
Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer
Jingjing Wu, Wen Xu, Lina Ma, et al.
Aging (2021) Vol. 13, Iss. 14, pp. 18191-18222
Open Access | Times Cited: 29
Jingjing Wu, Wen Xu, Lina Ma, et al.
Aging (2021) Vol. 13, Iss. 14, pp. 18191-18222
Open Access | Times Cited: 29
Role of the cGAS-STING pathway in radiotherapy for non-small cell lung cancer
Chunsheng Yang, Liang Yan, Ning Liu, et al.
Radiation Oncology (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 11
Chunsheng Yang, Liang Yan, Ning Liu, et al.
Radiation Oncology (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 11
The LncRNA FGD5‐AS1/miR‐497‐5p axis regulates septin 2 (SEPT2) to accelerate cancer progression and increase cisplatin‐resistance in laryngeal squamous cell carcinoma
Kaibin Song, Pingyang Yu, Cong Zhang, et al.
Molecular Carcinogenesis (2021) Vol. 60, Iss. 7, pp. 469-480
Closed Access | Times Cited: 24
Kaibin Song, Pingyang Yu, Cong Zhang, et al.
Molecular Carcinogenesis (2021) Vol. 60, Iss. 7, pp. 469-480
Closed Access | Times Cited: 24
A Signature of 14 Long Non-Coding RNAs (lncRNAs) as a Step towards Precision Diagnosis for NSCLC
Anetta Sulewska, Jacek Nikliński, Radosław Charkiewicz, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 439-439
Open Access | Times Cited: 16
Anetta Sulewska, Jacek Nikliński, Radosław Charkiewicz, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 439-439
Open Access | Times Cited: 16
MicroRNA-520a Suppresses Pathogenesis and Progression of Non-Small-Cell Lung Cancer through Targeting the RRM2/Wnt Axis
Yi Xie, Congyu Xue, Shuai Guo, et al.
Analytical Cellular Pathology (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 21
Yi Xie, Congyu Xue, Shuai Guo, et al.
Analytical Cellular Pathology (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 21
A new cell-free therapeutic strategy for liver regeneration: Human placental mesenchymal stem cell-derived extracellular vesicles
Ting Li, Yu Fu, Zeyi Guo, et al.
Journal of Tissue Engineering (2022) Vol. 13
Open Access | Times Cited: 14
Ting Li, Yu Fu, Zeyi Guo, et al.
Journal of Tissue Engineering (2022) Vol. 13
Open Access | Times Cited: 14
Second generation androgen receptor antagonist, TQB3720 abrogates prostate cancer growth via AR/GPX4 axis activated ferroptosis
Zhongqing Zhang, Tianlei Xie, Shun Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Zhongqing Zhang, Tianlei Xie, Shun Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Emerging roles of non-coding RNAs in modulating the PI3K/Akt pathway in cancer
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Saba Asadi, et al.
Non-coding RNA Research (2024) Vol. 10, pp. 1-15
Open Access | Times Cited: 2
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Saba Asadi, et al.
Non-coding RNA Research (2024) Vol. 10, pp. 1-15
Open Access | Times Cited: 2
Diagnostic, prognostic, and therapeutic significance of miR-139-5p in cancers
Neda Khalili, Masoud Nouri‐Vaskeh, Zahra Hasanpour Segherlou, et al.
Life Sciences (2020) Vol. 256, pp. 117865-117865
Closed Access | Times Cited: 21
Neda Khalili, Masoud Nouri‐Vaskeh, Zahra Hasanpour Segherlou, et al.
Life Sciences (2020) Vol. 256, pp. 117865-117865
Closed Access | Times Cited: 21
LncRNA AFAP-AS1 promotes anaplastic thyroid cancer progression by sponging miR-155-5p through ETS1/ERK pathway
Mingliang Ning, Shaojie Qin, Jia Tian, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 1543-1554
Open Access | Times Cited: 19
Mingliang Ning, Shaojie Qin, Jia Tian, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 1543-1554
Open Access | Times Cited: 19
The Impact of lncRNAs and miRNAs on Apoptosis in Lung Cancer
Soudeh Ghafouri‐Fard, Amin Aghabalazade, Hamed Shoorei, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 19
Soudeh Ghafouri‐Fard, Amin Aghabalazade, Hamed Shoorei, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 19